Retrospective analyses of clinical tumor samples identify TGFβ1 as the most prevalent TGFβ isoform in most solid cancers Preclinical results demonstrate highly selective inhibition of TGFβ1 activation ...
- Preclinical results demonstrate highly selective inhibition of TGFβ1 activation with SRK-181-mIgG1 overcomes key mechanism of primary resistance to checkpoint inhibition therapy - Selective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results